Concordance of the toxicity of pharmaceuticals in humans and in animals.

@article{Olson2000ConcordanceOT,
  title={Concordance of the toxicity of pharmaceuticals in humans and in animals.},
  author={H. Olson and Graham R Betton and Dylan Robinson and Karluss Thomas and Alastair Monro and Gerald J. Kolaja and Peter Lilly and J. Sanders and Glenn Sipes and Wendy S. Bracken and M Dorato and Katrijn Van Deun and Penelope Probert Smith and Bernard Berger and A Heller},
  journal={Regulatory toxicology and pharmacology : RTP},
  year={2000},
  volume={32 1},
  pages={
          56-67
        }
}
  • H. Olson, Graham R Betton, +12 authors A Heller
  • Published in
    Regulatory toxicology and…
    2000
  • Medicine
  • This report summarizes the results of a multinational pharmaceutical company survey and the outcome of an International Life Sciences Institute (ILSI) Workshop (April 1999), which served to better understand concordance of the toxicity of pharmaceuticals observed in humans with that observed in experimental animals. The Workshop included representatives from academia, the multinational pharmaceutical industry, and international regulatory scientists. The main aim of this project was to examine… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 760 CITATIONS, ESTIMATED 63% COVERAGE

    Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

    VIEW 4 EXCERPTS
    CITES RESULTS, BACKGROUND & METHODS
    HIGHLY INFLUENCED

    Investigative safety strategies to improve success in drug development

    VIEW 6 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    Concordance of Noncarcinogenic Endpoints in Rodent Chemical Bioassays.

    • Bing Wang, George M Gray
    • Biology, Medicine
    • Risk analysis : an official publication of the Society for Risk Analysis
    • 2015
    VIEW 5 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    Drug Development and Nonclinical to Clinical Translational Databases

    VIEW 7 EXCERPTS
    CITES BACKGROUND & METHODS
    HIGHLY INFLUENCED

    Animal models of toxicology testing: the role of pigs.

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Integrated and translational nonclinical in vivo cardiovascular risk assessment: gaps and opportunities.

    VIEW 5 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    FILTER CITATIONS BY YEAR

    2000
    2020

    CITATION STATISTICS

    • 39 Highly Influenced Citations

    • Averaged 75 Citations per year from 2017 through 2019

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 29 REFERENCES

    What does the clinician want to know from the toxicologist?

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    CMR News, Vol

    • CMR
    • 17. Centre for Medicines Research International, Epsom, Surrey, UK.
    • 1999
    VIEW 2 EXCERPTS

    COSTART: Coding symbols for Thesaurus of Adverse Reaction Items, Version 5

    • National Technical Information Service
    • National Technical Information Service, Springfield, VA.
    • 1999
    VIEW 1 EXCERPT

    Activities of the international pharmaceutical industry in 1997: Pharmaceutical investment and output

    • G. A. Ashton, L. I. Lobo, S. A. Griffiths, N. McAuslane
    • Centre Med. Res. CMR 98–104R.
    • 1998
    VIEW 2 EXCERPTS

    Seiyakukyo data No

    • JPMA
    • 65. Translation of a report from the Japanese Pharmaceutical Manufacturers Association, provided by Dr. T. Igarashi.
    • 1994
    VIEW 1 EXCERPT

    Seiyakukyo data No . 65 . Translation of a report from the Japanese Pharmaceutical Manufacturers Association , provided by Dr . T . Igarashi

    • D. R. Lawrence, A. E. M. McLean, M. Weatheral
    • 1994